A Collaboration for Progress

MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries.

Read more

MRM Proteomics Turns ten!

MRM Proteomics Inc. turned 10 years old in August. In the past ten years we have moved from being a small company to expanding globally. We sincerely would like to thank all of our clientele for their support; without them we would not be where we were today. MRM Proteomics Inc. will continue to provide a high quality of technologies for Proteomics and Metabolomics. Here is to celebrating 10 years of Science!

Thank you!

Advancing the gold standard

In Proteomics Technologies

LATEST PUBLICATIONS

Mar 2022

Mohammed Y, Touw CE, Nemeth B, van Adrichem RA, Borchers CH, Rosendaal FR, van Vlijmen BJ, Cannegieter SC

JOURNAL OF THROMBOSIS & HAEMOSTASTIS

Feb 2022

Brzhozovskiy A, Kononikhin A, Bugrova AE, Kovalev GI, Schmit PR, Kruppa G, Nikolaev EV, Borchers CH

ANALYTICAL CHEMISTRY

LATEST NEWS

Spring has Sprung Promotion

Take advantage of our spring promotion and unlock the potential of your bottom-up MS proteomic and metabolomic developments with the PeptiQuant™ Plus and MetaboloMetrics™ kits! These readily available kits provide a thorough MRM-MS strategy with paired labeled and unlabeled standards to ensure robust, reproducible, and interference-free measurements.  Whether you’re interested in cancer, CVD, or other research areas, our carefully selected panels are able to assist your research needs.

Our spring promotion also applies to our high quality services. View our service profile to see which one fits with your project.

  Contact us now!

A Collaboration for Progress

MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries. This new partnership will provide a complete solution for quantitative protein and metabolite analysis. Agilent’s advanced expertise and state-of-the-art mass spectrometry technology, along with MRMP’s leadership and experience in peptide and metabolite quantitation will enable the development of new tools and technologies to advance the field of multi-omics. Read more about this exciting collaboration.

Structural Proteomics for Treating Neurodegenerative Diseases

The highly influential journal “Chemical Reviews” recently published a review where our CSO and Co-founder Christoph Borchers and McGill scientist Evgeniy Petrotchenko discuss the potential of structural proteomics for treating neurodegenerative diseases. “This field combines protein chemistry and mass spectrometry, an advanced analytical technique for identifying the chemical composition of substances based on precise mass. The ultimate goal is to resolve the detailed structure of proteins and therefore understand pathological processes, like Alzheimer’s, on the molecular level and predict drug candidates against diverse diseases faster and more efficiently.”

Technology networks full news article link.

Advancing Proteomics Technology

MRM Proteomics Inc. is at the leading edge of proteomics technology. We offer a wide variety of proteomics services for protein quantitation, structural characterization, tissue imaging and a line of easy-to-use proteomics kits.

SERVICES

MRM Proteomics Inc. offers a wide range of services to fit a wide variety of projects…

PRODUCTS

Our complementary line of quality control products will help to ensure that your …

CLINICAL DIAGNOSTICS

The development of laboratory-developed tests (LDTs) will provide health-care…